OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript March 5, 2026 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.51, expectations were $0.23. Operator: Good ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript March 5, 2026 Evogene Ltd. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.26. Operator: Welcome to ...

Punjab CM unveils new industrial policy 2026 to boost investment, generate employment, and offer customized incentives.